ABC11

FDA recall: Erectile dysfunction drug found in honey energy supplement

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...

FDA announces Abbott Diabetes Care glucose monitor sensor recall

Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...

ASX 200 healthcare stock sinks 9% on FDA update

Let's see what this stock has announced on Thursday. The post ASX 200 healthcare stock sinks 9% on FDA update appeared first ...
MPR

Incorrect Readings Prompt Recall of Certain Abbott Glucose Sensors

FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.
Physicians Committee for Responsible MedicineOpinion

Protein Food Label Requirement Disadvantages Plant-Based Protein, Scientists Argue in Current Developments in Nutrition

U.S. and Canadian food labeling regulations require that protein digestibility be tested in rats to substantiate protein ...

Experimental cholesterol-lowering pill may offer new option for millions

A new kind of pill sharply reduced cholesterol in people at high risk of heart attacks despite taking statins.
American Hospital Association

FDA issues most serious recall for certain glucose monitor sensors

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors by Abbott Diabetes Care due to incorrect glucose readings that are ...
KTVU FOX 2

FDA: Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors recalled after seven deaths, 860 injuries

The Food and Drug Administration (FDA) has now identified the recall of certain FreeStyle Libre glucose monitor sensors as ...

Rising Alzheimer’s rates prompt federal aid and new scientific findings on disease prevention and detection

According to the National Institute on Aging, 6.9 million Americans are living with Alzheimer’s disease today. As the ...
The Daily SignalOpinion

The FDA’s Lethargy Is Harming Women and Overburdening Doctors

American women are silently suffering while the FDA drags its feet on reviewing the abortion drug mifepristone.